by admin | Apr 9, 2019 | Company News
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) — Denmark-based Vilacto Bio Inc. (OTC QB: VIBI) is happy to announce that the company has decided to introduce 2 new products and present them for the market later this summer/fall. The company will present one product...
by admin | Mar 26, 2019 | Company News
Vilacto Bio Canada Patent LACTOACTIVE® Granted Press Release | 03/15/2019 NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) — Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company...
by admin | Nov 30, 2018 | Company News
Vilacto Bio Secured Patent Applications for LACTOACTIVE® NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) — New York-based Vilacto Bio Inc. (OTC QB:VIBI) has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong. The...
by admin | Oct 1, 2018 | Company News
Vilacto Bio Announces Launch of Carmen Electra by Vilact® Press Release | 10/01/2018 COPENHAGEN, Denmark, Oct. 01, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTC QB:VIBI) has launched its new skincare product, Carmen Electra by Vilact, based on the company’s...
by admin | Sep 21, 2018 | Company News
Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER® Press Release | 09/21/2018 COPENHAGEN, Denmark, Sept. 21, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTC QB:VIBI) has revealed the initial five areas of development for its new LACTOACTIVE iTHER®...
by admin | Sep 10, 2018 | Company News
Vilacto Bio Introduces New LACTOACTIVE iTHER® Compound Press Release | 09/10/2018 COPENHAGEN, Denmark, Sept. 10, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTC QB:VIBI) has launched its LACTOACTIVE iTHER® product. LACTOACTIVE iTHER® is a new LACTOACTIVE variant...
